Kenya vs Saudi Arabia: Access to anti-retroviral drugs, female
Kenya
90.0%
in 2024
Saudi Arabia
91.0%
in 2024
Kenya rank
27th
Saudi Arabia rank
25th
Access to anti-retroviral drugs, female over time
- Kenya
- Saudi Arabia
How they compare
Saudi Arabia currently reports 91.0% against 90.0% in Kenya, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Saudi Arabia ahead.
Kenya ranks 27th and Saudi Arabia ranks 25th of 141 countries.
Across the 3 decades both report, Kenya averaged higher in 2 and Saudi Arabia in 1.
Head to head by decade
| Decade | Kenya | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.7% | 24.3% | 17.6% | Saudi Arabia |
| 2010s | 63.6% | 62.5% | 1.1% | Kenya |
| 2020s | 87.2% | 83.2% | 4.0% | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Kenya or Saudi Arabia?
- Saudi Arabia, at 91.0% against 90.0% in Kenya as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Kenya and Saudi Arabia?
- 1.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Kenya and Saudi Arabia?
- 25 years are reported by both, from 2000 to 2024.
- How do Kenya and Saudi Arabia rank globally for access to anti-retroviral drugs, female?
- Kenya ranks 27th and Saudi Arabia ranks 25th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.